Natriuretic peptides during the development of doxorubicin‐induced left ventricular diastolic dysfunction

Abstract

The results of this prospective study show that during the evolution of doxorubicin-induced LV dysfunction the secretion of natriuretic peptides is more closely associated with the impairment of left ventricular diastolic filling than with the deterioration of LV systolic function.